GRACEcast Naturopathic/CAM Audio
cancerGRACE - H. Jack West, MD
Add to My Podcasts
Episodes
About
Reviews
Promote
MET-Amplified Lung Cancer: A New Target for XALKORI?
7 minutes
Posted Jul 3, 2014 at 7:00 pm.
0:00
7:18
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.
Watch Video
Previous
The Hottest Thing in Late Stage Kidney Cancer
Next
Treating Newly Diagnosed Kidney Cancer
← See all 300 episodes of GRACEcast Naturopathic/CAM Audio